DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

Novartis (NYSE: NVS)

92.69 0.74 (0.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $92.69 0.80%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.42
Previous Close $91.95
Daily Range $92.24 - $92.93
52-Week Range $76.36 - $95.50
Market Cap $224.2B
P/E Ratio 24.85
Dividend (Yield) $2.72 (2.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 966,997
Average Daily Volume 1,607,699
Current FY EPS $5.20





Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary Rss Feed

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb reported third-quarter earnings last week. Here are five things management wants investors to know.

Incyte Gains on Q3 Earnings and Revenue Beat, Raises View - Analyst Blog

Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 03, 2014

Veeva Systems Flies High On Cloud For Life Sciences

Noteworthy ETF Outflows: VEU, NSRGY, NVS, BP

5 Things GlaxoSmithKline plc Stock's Management Wants You to Know

GlaxoSmithKline held its third-quarter conference call last week. Here's what the company's management wants you to know.

Novartis (NVS) Beats on Q3 Earnings, Revenues; Keeps View - Analyst Blog

Novartis: Continued Operating Strength, Shares Fairly Valued

United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog

Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off

Pfizer's third-quarter earnings report points to strength in emerging markets and select segments of its business, but also lends to the reality that a turnaround could be a long time coming.

See More NVS News...

NVS's Top Competitors

NVS $92.69 (0.80%)
Current stock: NVS
MRK $57.94 (1.10%)
Current stock: MRK
PFE $29.95 (0.37%)
Current stock: PFE
GSK $45.49 (0.78%)
Current stock: GSK